| Literature DB >> 16794639 |
Steven Gutman1, Larry G Kessler.
Abstract
Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?Entities:
Mesh：
Substances：
Year: 2006 PMID： 16794639 DOI： 10.1038/nrc1911
Source DB: PubMed Journal: Nat Rev Cancer ISSN： 1474-175X Impact factor: 60.716